1. From Valeriana officinalis to cancer therapy: the success of a bio-sourced compound
- Author
-
Hamaidia, M., Barez, PY., Carpentier, A., Lebecque, S., Miazek, K., Paul, A., Sriramareddy, SN., Staumont, B., Danthine, S., Deleu, M., Frederich, M., De Pauw, E., Delaplace, P., Delvigne, F., Goffin, D., Ongena, M., Duysinx, B., Louis, R., Cosse, JP., and Willems, L.
- Subjects
Valeriana officinalis ,medicinal properties ,epilepsy ,chromatin ,gene expression ,neoplasms ,Biotechnology ,TP248.13-248.65 ,Environmental sciences ,GE1-350 - Abstract
Introduction. Over the centuries, bio-sourced compounds isolated from plants, insects and microorganisms have been a potent source of drugs for the treatment of human diseases. Literature. Bio-sourced extracts offer a wide diversity of compounds with a large number of potentially beneficial effects in humans. Serendipity has frequently played a key role in the discovery of new medicines. The canonical discovery of penicillin required both chance and a prepared mind to understand and exploit its potential for the treatment of human infections. Nowadays, most anti-cancer drugs currently in clinical use were at least partly discovered by a "fortunate happenstance". Conclusions. In this review, we recapitulate the story of one of these compounds, 2-propylpentanoic acid, derived from the Valeriana officinalis flowering plant and its path to validation as a cancer treatment.
- Published
- 2016